Guidelines accompanied by changes in reimbursement rules. Effects on lipid-lowering drug prescribing
Research output: Contribution to journal › Journal article › peer-review
Standard
Guidelines accompanied by changes in reimbursement rules. Effects on lipid-lowering drug prescribing. / Bjerrum, L; Larsen, J; Kragstrup, J.
In: Scandinavian Journal of Primary Health Care, Vol. 19, No. 3, 09.2001, p. 158-62.Research output: Contribution to journal › Journal article › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Guidelines accompanied by changes in reimbursement rules. Effects on lipid-lowering drug prescribing
AU - Bjerrum, L
AU - Larsen, J
AU - Kragstrup, J
PY - 2001/9
Y1 - 2001/9
N2 - OBJECTIVE: To analyse the effect of guidelines accompanied by changes in reimbursement rules for the prescription of lipid-lowering drugs (LLDs).DESIGN: Observational study focusing on LLD use before (1994-98) and after an intervention (1999).SETTING: Guidelines were developed by the Danish College of General Practitioners and focused on prevention of cardiovascular heart disease (CHD). Guidelines were sent out and changes in reimbursement took place in December 1998. Prescriptions for LLDs were extracted from a population-based prescription database (Odense University Pharmacoepidemiological Database, OPED) covering 10% of the Danish population (470,000 inhabitants).MAIN OUTCOME MEASURES: Incidence rate and 1 year prevalence rate (annual prevalence) of LLD use.RESULTS: The incidence of LLD use increased significantly in the year following the intervention. Incidence rate ratio (after/before) was 1.43 (CI 1.35-1.52). The annual prevalence of LLD use in the population increased by 0.4% after the intervention (0.2% before). The corresponding figure for patients with diabetes mellitus (treated with insulin or oral anti-diabetics) was 2.3% after the intervention (1.2% before), and for patients with CHD (treated with vasodilators) 8.1% after the intervention (5.0% before).CONCLUSION: Guidelines accompanied by a change in reimbursement rules had a significant influence on the prescribing of lipid-lowering drugs.
AB - OBJECTIVE: To analyse the effect of guidelines accompanied by changes in reimbursement rules for the prescription of lipid-lowering drugs (LLDs).DESIGN: Observational study focusing on LLD use before (1994-98) and after an intervention (1999).SETTING: Guidelines were developed by the Danish College of General Practitioners and focused on prevention of cardiovascular heart disease (CHD). Guidelines were sent out and changes in reimbursement took place in December 1998. Prescriptions for LLDs were extracted from a population-based prescription database (Odense University Pharmacoepidemiological Database, OPED) covering 10% of the Danish population (470,000 inhabitants).MAIN OUTCOME MEASURES: Incidence rate and 1 year prevalence rate (annual prevalence) of LLD use.RESULTS: The incidence of LLD use increased significantly in the year following the intervention. Incidence rate ratio (after/before) was 1.43 (CI 1.35-1.52). The annual prevalence of LLD use in the population increased by 0.4% after the intervention (0.2% before). The corresponding figure for patients with diabetes mellitus (treated with insulin or oral anti-diabetics) was 2.3% after the intervention (1.2% before), and for patients with CHD (treated with vasodilators) 8.1% after the intervention (5.0% before).CONCLUSION: Guidelines accompanied by a change in reimbursement rules had a significant influence on the prescribing of lipid-lowering drugs.
KW - Aged
KW - Coronary Disease/etiology
KW - Denmark
KW - Diabetes Complications
KW - Drug Prescriptions/economics
KW - Drug Utilization/statistics & numerical data
KW - Female
KW - Humans
KW - Hypolipidemic Agents/therapeutic use
KW - Male
KW - Middle Aged
KW - Practice Guidelines as Topic
KW - Reimbursement Mechanisms/organization & administration
U2 - 10.1080/028134301316982379
DO - 10.1080/028134301316982379
M3 - Journal article
C2 - 11697556
VL - 19
SP - 158
EP - 162
JO - Scandinavian Journal of Primary Health Care
JF - Scandinavian Journal of Primary Health Care
SN - 0281-3432
IS - 3
ER -
ID: 324187648